文献速递临床试验与 GCP基础与转化研究

创伤性出血的院前全血输血随机对照试验

Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial.
PubMed 文献 · N Engl J Med · 2026-03-17

该研究为在英格兰10个空中救护服务开展的实用性3期多中心非盲随机优效性试验,纳入重大创伤性出血患者,比较院前输注全血(最多2单位)与标准成分输血(红细胞和血浆各最多2单位)的效果。主要结局为随机化后24小时内全因死亡或大量输血(≥10单位血成分或制品)的复合终点。结果显示两组主要结局发生率分别为48.7%和47.7%,全血输血并未优于标准治疗(相对风险1.02;95%CI 0.80-1.31;P=0.84)。

要点

  • 院前输注2单位全血未降低24小时内死亡或大量输血风险。
  • 全血组与标准治疗组主要结局事件发生率分别为48.7%和47.7%。
  • 全血组凝血酶原时间高于正常范围者占40.7%,标准治疗组为30.5%。

核心结论

  • 在危及生命的出血患者中,院前输注2单位全血在降低24小时内死亡或大量输血风险方面不优于标准成分输血治疗。

研究设计与样本

  • 实用性、3期、多中心、非盲、随机、优效性试验,在英格兰10个空中救护服务开展。
  • 共942例患者随机化,排除非创伤性出血或创伤性心脏骤停后,616例纳入分析(全血组314例,标准治疗组302例)。

主要发现

  • 主要结局事件在全血组发生率为48.7%,标准治疗组为47.7%(相对风险1.02;95%CI 0.80-1.31;P=0.84)。
  • 全因死亡、大量输血及其他次要结局在两组间表现相似。
  • 凝血酶原时间高于正常范围者全血组占40.7%,标准治疗组占30.5%。
  • 标准治疗组严重不良事件多于全血组(分别为37和31例)。
  • 血栓事件发生率在两组间表现相似。

临床怎么用

  • 对于重大创伤性出血患者,院前输注2单位全血不应被视为优于标准成分输血的选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. METHODS: We conducted a pragmatic, phase 3, multicenter, unblinded, randomized, superiority trial across 10 air ambulance services in England. Patients with major traumatic hemorrhage who were attended by a participating air ambulance service were randomly assigned to receive either whole-blood transfusion (up to 2 units) or standard care with blood components (up to 2 units each of red cells and plasma) before arrival at the hospital. The primary outcome was a composite of death from any cause or massive transfusion (≥10 units of blood components or products) within 24 hours after randomization. RESULTS: A total of 942 patients underwent randomization. After the exclusion of participants with nontraumatic hemorrhage or traumatic cardiac arrest, 616 were included in the analysis (314 in the whole-blood group and 302 in the standard-care group). A primary-outcome event occurred in 48.7% of the participants in the whole-blood group and in 47.7% of those in the standard-care group (relative risk, 1.02; 95% confidence interval, 0.80 to 1.31; P = 0.84). The incidence of death from any cause at all time points, massive transfusion, and other secondary outcomes appeared to be similar in the two groups. Prothrombin times were above the normal range in 40.7% of the participants in the whole-blood group and in 30.5% of those in the standard-care group. More serious adverse events occurred in the standard-care group than in the whole-blood group (37 and 31, respectively). The incidence of thrombotic events appeared to be similar in the two groups. CONCLUSIONS: Among participants with life-threatening hemorrhage, prehospital transfusion of 2 units of whole blood was not superior to standard care in reducing the risk of death or massive transfusion within 24 hours. (Funded by NHS Blood and Transplant and others; ISRCTN Registry number, ISRCTN23657907.).

来源:N Engl J Med,查看原文。版权归原作者所有。

引用

  1. Smith JE, Cardigan R, Sanderson E, et al. Prehospital Whole Blood in Traumatic Hemorrhage - A Randomized Controlled Trial. N Engl J Med. 2026. PMID: 41841706. doi:10.1056/NEJMoa2516043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。